Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Exploiting MEK Inhibitor-Mediated Activation of ERα for Therapeutic Intervention in ER-Positive Ovarian Carcinoma

  • June Y. Hou,
  • Alicia Rodriguez-Gabin,
  • Leleesha Samaraweera,
  • Rachel Hazan,
  • Gary L. Goldberg,
  • Susan Band Horwitz,
  • Hayley M. McDaid

The third author’s name is spelled incorrectly. The correct name is: Leleesha Samaraweera. The correction citation is: Hou JY, Rodriguez-Gabin A, Samaraweera L, Hazan R, Goldberg GL, Horwitz SB, et al. (2013) Exploiting MEK Inhibitor-Mediated Activation of ERα for Therapeutic Intervention in ER-Positive Ovarian Carcinoma. PLoS ONE 8(2): e54103. doi:10.1371/journal.pone.0054103.

Reference

  1. 1. Hou JY, Rodriguez-Gabin A, Samaweera L, Hazan R, Goldberg GL, Horwitz SB, et al. (2013) Exploiting MEK Inhibitor-Mediated Activation of ERα for Therapeutic Intervention in ER-Positive Ovarian Carcinoma. PLoS ONE 8(2): e54103. pmid:23390495

Citation: Hou JY, Rodriguez-Gabin A, Samaraweera L, Hazan R, Goldberg GL, Horwitz SB, et al. (2016) Correction: Exploiting MEK Inhibitor-Mediated Activation of ERα for Therapeutic Intervention in ER-Positive Ovarian Carcinoma. PLoS ONE 11(3): e0151750. https://doi.org/10.1371/journal.pone.0151750

Published: March 11, 2016

Copyright: © 2016 Hou et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.